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Abstract
Targeted temperature management (TTM) had been shown to limit 
neurological damage that is incurred in the post- cardiac arrest period, 
following return of spontaneous circulation (ROSC). Previous goal 
therapeutic temperatures ranged from 32°C to 34°C, however recent 
guidelines have suggested including temperatures up to 36°C. This review 
analyzes the difference in mortality and neurologic function outcomes 
between groups cooled to 32-34°C and 36°C. Although more research is 
needed to measure adverse events at each temperature, 36°C appears to be 
equally efficacious at preserving neurologic function. 
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Introduction
Methods
A literature search was conducted in November 2019 in the PubMed and 
Ovid databases. A total of six articles, randomized controlled trials and 
retrospective studies, were selected based on relevance to the research 
question, study design and population demographics. 
Inclusion Criteria
Ø Out- of- hospital cardiac arrest
Ø TTM
Ø Neurologic function 
Ø Randomized controlled trials
Ø Retrospective studies 
• While TTM has been accepted in clinical practice, the protocol for 
obtaining, achieving and terminating this treatment remains poorly 
understood
• All studies looked compared the temperature of 36°C to the range of 
32°C -34°C, with 33°C being the most common temperature in the 
latter group 
• Casamento and colleagues and Bray and colleagues also measured 
adverse outcomes with rates of shivering and fever being statistically 
less in the 36°C groups
• Direction for further research
Limitations
• only 2 were randomized controlled trials
• Variation in the patient population due to comorbidities that may 
influence the outcome of treatment with TTM
• The inability to control for other variables, such as method of cooling 
and type of sedation 
Discussion Results 
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Targeted Temperature Management at 36°C in 
the Treatment of Out- of- Hospital Cardiac Arrest
TTM at 36°C should be considered an equally valid treatment as it 
pertains to neurologic outcomes in patients experiencing OHCA when 
compared to TTM at 32°C- 34°C. Further research should consider the 
adverse events, effects on other body systems, long term outcomes and 
feasibility of obtaining and sustaining a temperature of 36°C. 
Conclusion
An analysis of the articles revealed that there was no 
statistically significant difference in mortality or neurologic 
function between the 32°C- 34°C group and the 36°C group 
in all studies that investigated these outcomes. The majority 
of the studies used the Cerebral Performance Category (CPC) 
as the form of measurement for neurologic functioning, and 
this review found congruency in results across studies using 
this method. Other studies used different rating scales that 
cannot be directly compared but showed similar outcomes in 
relation to neurologic functioning. Some studies also 
measured adverse events that occurred during treatment and 
found that the 36°C groups had lower rates of shivering, 





Ø Metanalyses  
Ø Systematic reviews
Ø Case studies 
Cardiac Arrest:
Ø Over 500,000 deaths/year in the US alone 
Ø Mortality rate of 85%
Ø Of those that survive: 5% with full neurologic function 
Primary Injury: cerebral hypoxia during decrease perfusion
Secondary Injury: Post cardiac arrest syndrome during reperfusion 
The role of therapeutic hypothermia in combatting cerebral injury: 
Ø Decreases cerebral metabolism by 5-10% for every 1°C below baseline 
Ø Decreases vascular permeability of the blood-brain-barrier
Ø 2010 AHA guideline update: target temperature of 32- 36°C, sustained 
for 24 hours with no absolute contraindications to treatment






Neilson et al NS NS NS
Lilia et al NS n/a NS
Arvidsson et al NS NS NS
Bray et al NS NS n/a
Irisawa et al NS NS NS
Casamento et al n/a n/a n/a
Study Shivering Bleeding Fever Arrythmia
Bray et al S n/a S n/a
Casamento 
et al 
S S S S
S= Significant (P- value of <0.05), NS= Not Significant (P- value of >0.05)
S= Significant (P- value of <0.05), NS= Not Significant (P- value of >0.05)
